Skip to main content
Erschienen in: Metabolic Brain Disease 1/2019

09.10.2018 | Original Article

Adipocyte proteome and secretome influence inflammatory and hormone pathways in glioma

verfasst von: J. Almeida, J. Costa, P. Coelho, V. Cea, M. Galesio, J. P. Noronha, M. S. Diniz, C. Prudêncio, R. Soares, C. Sala, Rúben Fernandes

Erschienen in: Metabolic Brain Disease | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Gliomas represent the most common primary malignant brain tumors in adults, with an extremely poor prognosis. Among several risk factors, lifestyle was also recently identified as a major risk factor for the development of primary glioma. In the present study, we explore the relationship between obesity and glioma in a cellular model. Thus, we have study the influence of adipocytes secretome on glioma cell line GL261. Using the 3T3-L1 adipocyte cell line, and its conditioned medium (adipokines-enriched medium), we showed that adipocyte-released factors relate with glioma angiogenic, growth, hormones and metabolic behavior by MALDI-TOF-MS and proteomic array analysis. In a first view, STI1, hnRNPs and PGK1 are under expressed on CGl. Similarly, both carbonic anhydrase and aldose reductase are even suppressed in glioma cells that grown under adipokines-enriched environment. Contrariwise, RFC1, KIF5C, ANXA2, N-RAP and RACK1 are overexpressed in GL261 cell the in the presence of the adipokines-enriched medium. We further identified the factors that are released by adipocyte cells, and revealed that several pro-inflammatory and angiogenic factors, such as IL-6, IL-11, LIF, PAI-1, TNF-α, endocan, HGF, VEGF IGF-I, were secreted to the medium into a high extent, whereas TIMP-1 and SerpinE1 were under expressed on CGl. This study discloses an interesting in vitro model for the study of glioma biology under a “obesity” environment, that can be explored for the understanding of cancer cells biology, for the search of biomarkers, prognostic markers and therapeutic approaches.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Aoki T, Kato S, Fox JC, Okamoto K, Sakata K, Morimatsu M, Shigemori M (2002) Inhibition of autocrine fibroblast growth factor signaling by the adenovirus-mediated expression of an antisense transgene or a dominant negative receptor in human glioma cells in vitro. Int J Oncol 21:629–636PubMed Aoki T, Kato S, Fox JC, Okamoto K, Sakata K, Morimatsu M, Shigemori M (2002) Inhibition of autocrine fibroblast growth factor signaling by the adenovirus-mediated expression of an antisense transgene or a dominant negative receptor in human glioma cells in vitro. Int J Oncol 21:629–636PubMed
Zurück zum Zitat Candolfi M, Curtin JF, Nichols WS, Muhammad AKMG, King GD, Pluhar GE, McNiel EA, Ohlfest JR, Freese AB, Moore PF, Lerner J, Lowenstein PR, Castro MG (2007) Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neuro-Oncol 85:133–148. https://doi.org/10.1007/s11060-007-9400-9 CrossRef Candolfi M, Curtin JF, Nichols WS, Muhammad AKMG, King GD, Pluhar GE, McNiel EA, Ohlfest JR, Freese AB, Moore PF, Lerner J, Lowenstein PR, Castro MG (2007) Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neuro-Oncol 85:133–148. https://​doi.​org/​10.​1007/​s11060-007-9400-9 CrossRef
Zurück zum Zitat Disney-Hogg L, Sud A, Law PJ, Cornish AJ, Kinnersley B, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Il’yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Swerdlow AJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Houlston RS (2018) Influence of obesity-related risk factors in the aetiology of glioma. Br J Cancer 118:1020–1027. https://doi.org/10.1038/s41416-018-0009-x CrossRefPubMedPubMedCentral Disney-Hogg L, Sud A, Law PJ, Cornish AJ, Kinnersley B, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Il’yasova D, Schildkraut J, Barnholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Swerdlow AJ, Simon M, Hoffmann P, Nöthen MM, Jöckel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Houlston RS (2018) Influence of obesity-related risk factors in the aetiology of glioma. Br J Cancer 118:1020–1027. https://​doi.​org/​10.​1038/​s41416-018-0009-x CrossRefPubMedPubMedCentral
Zurück zum Zitat Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger F, May B, Milacic M, Roca CD, Rothfels K, Sevilla C, Shamovsky V, Shorser S, Varusai T, Viteri G, Weiser J, Wu G, Stein L, Hermjakob H, D’Eustachio P (2018) The Reactome pathway knowledgebase. Nucleic Acids Res 46:D649–D655. https://doi.org/10.1093/nar/gkx1132 CrossRefPubMed Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger F, May B, Milacic M, Roca CD, Rothfels K, Sevilla C, Shamovsky V, Shorser S, Varusai T, Viteri G, Weiser J, Wu G, Stein L, Hermjakob H, D’Eustachio P (2018) The Reactome pathway knowledgebase. Nucleic Acids Res 46:D649–D655. https://​doi.​org/​10.​1093/​nar/​gkx1132 CrossRefPubMed
Zurück zum Zitat Hossain A, Gumin J, Gao F, Figueroa J, Shinojima N, Takezaki T, Priebe W, Villarreal D, Kang SG, Joyce C, Sulman E, Wang Q, Marini FC, Andreeff M, Colman H, Lang FF (2015) Mesenchymal stem cells isolated from human gliomas increase proliferation and maintain stemness of glioma stem cells through the IL-6/gp130/STAT3 pathway. Stem Cells 33:2400–2415. https://doi.org/10.1002/stem.2053 CrossRefPubMedPubMedCentral Hossain A, Gumin J, Gao F, Figueroa J, Shinojima N, Takezaki T, Priebe W, Villarreal D, Kang SG, Joyce C, Sulman E, Wang Q, Marini FC, Andreeff M, Colman H, Lang FF (2015) Mesenchymal stem cells isolated from human gliomas increase proliferation and maintain stemness of glioma stem cells through the IL-6/gp130/STAT3 pathway. Stem Cells 33:2400–2415. https://​doi.​org/​10.​1002/​stem.​2053 CrossRefPubMedPubMedCentral
Zurück zum Zitat Luisa A, Stefano D, Enciso-mora V, et al (2012) Association between glioma susceptibility molecular etiologies. 1–6 Luisa A, Stefano D, Enciso-mora V, et al (2012) Association between glioma susceptibility molecular etiologies. 1–6
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P (2002) Global cancer statistics. CA Cancer J Clin 55:74–108CrossRef Parkin DM, Bray F, Ferlay J, Pisani P (2002) Global cancer statistics. CA Cancer J Clin 55:74–108CrossRef
Zurück zum Zitat Sielska M, Przanowski P, Wylot B, Gabrusiewicz K, Maleszewska M, Kijewska M, Zawadzka M, Kucharska J, Vinnakota K, Kettenmann H, Kotulska K, Grajkowska W, Kaminska B (2013) Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response. J Pathol 230:310–321. https://doi.org/10.1002/path.4192 CrossRefPubMed Sielska M, Przanowski P, Wylot B, Gabrusiewicz K, Maleszewska M, Kijewska M, Zawadzka M, Kucharska J, Vinnakota K, Kettenmann H, Kotulska K, Grajkowska W, Kaminska B (2013) Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response. J Pathol 230:310–321. https://​doi.​org/​10.​1002/​path.​4192 CrossRefPubMed
Metadaten
Titel
Adipocyte proteome and secretome influence inflammatory and hormone pathways in glioma
verfasst von
J. Almeida
J. Costa
P. Coelho
V. Cea
M. Galesio
J. P. Noronha
M. S. Diniz
C. Prudêncio
R. Soares
C. Sala
Rúben Fernandes
Publikationsdatum
09.10.2018
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 1/2019
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-018-0327-y

Weitere Artikel der Ausgabe 1/2019

Metabolic Brain Disease 1/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.